Back

Has the use of concomitant cardiac medications improved over time in primary prevention ICD patients? Insights from the APPRAISE ATP study

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Implantable/wearable devices and sudden cardiac death Cardioversion and Defibrillation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Lluis Mont

Hospital Clinic of Barcelona, Barcelona (Spain)

6 More presentations in this session

Presentation thumbnail
Changes in study enrollment of patients with non-ischemic cardiomyopathy receiving an ICD for primary prevention: Insights from the APPRAISE ATP study
Professor L. Mont (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Autopsy findings and cardiac arrest rhythms in young obese patients with sudden cardiac death of uncertain etiology
Doctor V. Goel (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Wearable cardioverter defibrillator after ICD-system explantation: data from a multicenter registry
Mrs K. Koepsel (Bochum, DE)
Abstract Slides Video
Presentation thumbnail
Long-term stability of atrial sensing in implantable cardioverter-defibrillators with floating atrial dipole leads
Doctor I. Ferreira Neves (Lisboa, PT)
Abstract Slides Video
Presentation thumbnail
Cardiac resynchronization therapy with or without defibrillation in patients with non-ischemic cardiomyopathy: a systematic review and meta-analysis
Doctor V. Devesa Neto (Viseu, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Implantable/wearable devices and sudden cardiac death

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources